Timing of chemotherapy (morning vs evening) for glioblastoma
Part of Cancer clinical trials.
This trial tests whether taking the chemotherapy drug temozolomide in the morning or in the evening works better and causes fewer side effects for people with a type of brain cancer called glioblastoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with a specific type of brain cancer called IDH-wildtype glioblastoma.
- You have already had surgery to remove as much of the tumor as possible.
- You have completed radiation therapy to the brain after surgery.
- You are planning to start up to 6 cycles of temozolomide chemotherapy within 8 weeks after finishing radiation.
- You are willing and able to fill out study questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy combined with the chemotherapy drug temozolomide for people with glioblastoma. It aims to see if this approach works as well as standard treatment while being more convenient.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial tests a daily chemo drug (temozolomide) in patients aged 65 or older with a specific type of aggressive brain cancer that has a certain genetic marker. It aims to see if this daily schedule works well after initial radiation and chemo.
This study compares a standard radiation schedule versus a shorter, higher-dose radiation schedule, both with the chemotherapy medicine temozolomide, in older adults with newly diagnosed glioblastoma. It aims to see which approach works better and is practical for people age 70 and older.
This study is testing whether a short course of chemotherapy (temozolomide) given before radiation can improve outcomes for people with newly diagnosed high-grade gliomas. It is designed for patients who are stable enough to delay starting radiation by a few weeks.
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.